Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease
Abstract Background As Parkinson's disease (PD) progresses, managing symptoms becomes increasingly difficult. Foslevodopa/foscarbidopa (LDp/CDp), a 24‐hour/day continuous subcutaneous infusion of levodopa/carbidopa (LD/CD) prodrugs, improves motor complications.
Jason Aldred+11 more
wiley +1 more source
Gender differences in prescribing patterns for patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databases. [PDF]
Seki M, Kawata Y, Hayashi A, Fujimoto S.
europepmc +1 more source
Successful treatment of childhood onset symptomatic dystonia with levodopa. [PDF]
Nicholas Fletcher+3 more
openalex +1 more source
A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier+12 more
wiley +1 more source
Symptom improvement in a South Asian patient with Parkinson's disease treated with immediate- and extended-release carbidopa-levodopa: a case report. [PDF]
Reiner G, Skipworth M.
europepmc +1 more source
Disposition of gamma‐glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers. [PDF]
YA Boateng+4 more
openalex +1 more source
Mucuna pruriens Treatment for Parkinson Disease: A Systematic Review of Clinical Trials. [PDF]
Hammoud F+4 more
europepmc +1 more source
Reappraisal of Temporary Levodopa Withdrawal (Drug Holiday) in Parkinson's Disease
Richard Mayeux+3 more
openalex +2 more sources
Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels [PDF]
Jaime Kulisevsky+5 more
openalex +1 more source